DE2754741A1 - Prostanderivate - Google Patents

Prostanderivate

Info

Publication number
DE2754741A1
DE2754741A1 DE19772754741 DE2754741A DE2754741A1 DE 2754741 A1 DE2754741 A1 DE 2754741A1 DE 19772754741 DE19772754741 DE 19772754741 DE 2754741 A DE2754741 A DE 2754741A DE 2754741 A1 DE2754741 A1 DE 2754741A1
Authority
DE
Germany
Prior art keywords
radical
alkyl
acid
trans
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772754741
Other languages
German (de)
English (en)
Inventor
Keith Hopkinson Gibson
Edward Raymond Halstead Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE2754741A1 publication Critical patent/DE2754741A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
DE19772754741 1976-12-08 1977-12-08 Prostanderivate Withdrawn DE2754741A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51196/76A GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives

Publications (1)

Publication Number Publication Date
DE2754741A1 true DE2754741A1 (de) 1978-06-15

Family

ID=10459023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772754741 Withdrawn DE2754741A1 (de) 1976-12-08 1977-12-08 Prostanderivate

Country Status (14)

Country Link
JP (1) JPS5371060A (enExample)
AU (1) AU3104477A (enExample)
BE (1) BE861652A (enExample)
CA (1) CA1119591A (enExample)
DE (1) DE2754741A1 (enExample)
DK (1) DK548177A (enExample)
FR (1) FR2373538A1 (enExample)
GB (1) GB1550399A (enExample)
IE (1) IE46170B1 (enExample)
IT (1) IT1089433B (enExample)
NL (1) NL7713587A (enExample)
NZ (1) NZ185822A (enExample)
SE (1) SE7713895L (enExample)
ZA (1) ZA777059B (enExample)

Also Published As

Publication number Publication date
AU3104477A (en) 1979-06-07
ZA777059B (en) 1978-08-30
FR2373538B1 (enExample) 1981-07-10
CA1119591A (en) 1982-03-09
JPS5371060A (en) 1978-06-24
BE861652A (fr) 1978-06-08
IE46170B1 (en) 1983-03-09
SE7713895L (sv) 1978-06-09
NL7713587A (nl) 1978-06-12
DK548177A (da) 1978-06-09
IE46170L (en) 1978-06-08
FR2373538A1 (fr) 1978-07-07
NZ185822A (en) 1979-03-16
GB1550399A (en) 1979-08-15
IT1089433B (it) 1985-06-18

Similar Documents

Publication Publication Date Title
DE2437388A1 (de) Prostansaeurederivate
CH637376A5 (de) Verfahren zur herstellung neuer prostansaeurederivate.
DE2517771A1 (de) Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
DE2223365C3 (de) Prostansäurederivate, Verfahren zu ihrer Herstellung, solche Derivate enthaltende pharmazeutische und veterinäre Zusammensetzungen sowie Zwischenprodukte zur Herstellung dieser Derivate
DE2356383A1 (de) Chemische zwischenprodukte, die sich zur herstellung von prostaglandinen und prostaglandinartigen verbindungen eignen
DE3226550A1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CH638773A5 (en) Prostane derivatives and process for their preparation
DE2322142C2 (de) Prostansäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische oder veterinäre Zuammensetzungen
DE2150361A1 (de) Prostanoesaeurederivate
CH636082A5 (de) Prostanderivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel.
DE2234709A1 (de) Prostanoesaeurederivate
DE2646878A1 (de) 11-desoxy-acetylen-aryl-prostaglandine sowie verfahren zu deren herstellung
DE2539116C2 (de) ω-Nor-cycloalkyl-13,14-dehydro-prostaglandine, Verfahren zu ihrer Herstellung sowie sie enthaltende pharmazeutische Mittel
DE2360893A1 (de) Cyclopentanderivate
DE2517801A1 (de) Prostansaeurederivate und verfahren zur herstellung derselben
DE2739277A1 (de) 11-deoxy-11-oxaprostaglandinverbindungen
DE2754741A1 (de) Prostanderivate
DE2404654A1 (de) Cyclopentanderivate
DE2626287A1 (de) Prostanderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittelzusammensetzung
DE2234708A1 (de) Prostanoesaeurederivate
DE2637384A1 (de) Prostanderivate
DE2736110A1 (de) Prostanderivate
DE2733976A1 (de) Neue cyanprostaglandine und verfahren zu deren herstellung
EP0113311B1 (de) 5-Fluorcarbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2209039A1 (enExample)

Legal Events

Date Code Title Description
8141 Disposal/no request for examination